KTRA News and Press, Kintara Therapeutics Inc Com From 04/03/24

A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 99.9% to $0.2007 on volume of 121,318,217 shares Next.e.GO N.V. (EGOX) rose 30.8% to $0.034 on volume of 63,981,361 shares C3is Inc. (CISS) rose 20.8% to $0.0494 on volume of 63,446,681 shares I...

2024-04-03 09:37:34 ET DENVER, Colo., Apr 03, 2024 ( 247marketnews.com )- Kintara Therapeutics, Inc. (NASDAQ: KTRA ) and TuHURA Biosciences, Inc. announced, this morning, that they agreed to an all-stock transaction to form a company with expertise and resources to advance a risk di...

2024-04-03 07:28:25 ET More on Kintara Therapeutics Financial information for Kintara Therapeutics Read the full article on Seeking Alpha For further details see: Kintara to merge with TuHURA Bio in all-stock deal

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement PR Newswire TuHURA is planning to advance a single Phase 3 trial for IFx-2.0 personalized cancer vaccine as adjunctive therapy with Keytruda® in first-line therapy for advanced Merkel cell ...

2024-03-31 06:26:00 ET 3 Tips for Sizing Your Penny Stocks Positions in 2024 Sizing positions correctly is a cornerstone of successful investing, especially when dealing with penny stocks. The unique nature of penny stocks , with their potential for substantial gains, requires a nua...

A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 54.8% to $0.2552 on volume of 35,107,796 shares Nikola Corporation (NKLA) rose 5.0% to $0.9546 on volume of 25,515,019 shares Biodexa Pharmaceuticals plc (BDRX) rose 83.9% to $1.58 on volume of 24,185,655 shar...

2024-03-27 09:21:07 ET More on Kintara Therapeutics Financial information for Kintara Therapeutics Read the full article on Seeking Alpha For further details see: Kintara Therapeutics expands REM-001 study to include patients on pembrolizumab

Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab PR Newswire SAN DIEGO , March 27, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on t...

2024-03-13 17:07:28 ET Gainers: Turtle Beach ( HEAR ) +22% . SoundHound ( SOUN ) +12% . Robinhood Markets ( HOOD ) +9% . Recursion Pharmaceuticals ( RXRX ) +7% . Pyxis Oncology ( PYXS ) +3% . Losers: WW International ( ...

2024-03-13 13:18:36 ET More on Mid-day movers & stocks. Arq, Inc. (ARQ) Q4 2023 Earnings Call Transcript Heron Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript Heron Therape...